CHPF
Chondroitin sulfate synthase 2
Also known as: CHSS2_HUMAN, CHSY2, CSS2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZ52
- Gene
- CHPF
- Ensembl
- ENSG00000123989
- Chromosome
- 2
- Canonical length
- 775 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles,Centrosome,Cytosol
OverviewNCBI Gene
Enables N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity and glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity. Predicted to be located in Golgi membrane. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
775 residues, UniProt reviewed canonical sequence.
>Q8IZ52|CHPF
1 MRASLLLSVL RPAGPVAVGI SLGFTLSLLS VTWVEEPCGP GPPQPGDSEL PPRGNTNAAR
61 RPNSVQPGAE REKPGAGEGA GENWEPRVLP YHPAQPGQAA KKAVRTRYIS TELGIRQRLL
121 VAVLTSQTTL PTLGVAVNRT LGHRLERVVF LTGARGRRAP PGMAVVTLGE ERPIGHLHLA
181 LRHLLEQHGD DFDWFFLVPD TTYTEAHGLA RLTGHLSLAS AAHLYLGRPQ DFIGGEPTPG
241 RYCHGGFGVL LSRMLLQQLR PHLEGCRNDI VSARPDEWLG RCILDATGVG CTGDHEGVHY
301 SHLELSPGEP VQEGDPHFRS ALTAHPVRDP VHMYQLHKAF ARAELERTYQ EIQELQWEIQ
361 NTSHLAVDGD QAAAWPVGIP APSRPASRFE VLRWDYFTEQ HAFSCADGSP RCPLRGADRA
421 DVADVLGTAL EELNRRYHPA LRLQKQQLVN GYRRFDPARG MEYTLDLQLE ALTPQGGRRP
481 LTRRVQLLRP LSRVEILPVP YVTEASRLTV LLPLAAAERD LAPGFLEAFA TAALEPGDAA
541 AALTLLLLYE PRQAQRVAHA DVFAPVKAHV AELERRFPGA RVPWLSVQTA APSPLRLMDL
601 LSKKHPLDTL FLLAGPDTVL TPDFLNRCRM HAISGWQAFF PMHFQAFHPA VAPPQGPGPP
661 ELGRDTGRFD RQAASEACFY NSDYVAARGR LAAASEQEEE LLESLDVYEL FLHFSSLHVL
721 RAVEPALLQR YRAQTCSARL SEDLYHRCLQ SVLEGLGSRT QLAMLLFEQE QGNSTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHPF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 105 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 105 nTPM
- heart muscle: 91 nTPM
- ovary: 88 nTPM
- pituitary gland: 84 nTPM
- pancreas: 82 nTPM
- testis: 68 nTPM
Single-cell type
- syncytiotrophoblasts: 376 nCPM
- extravillous trophoblasts: 258 nCPM
- cytotrophoblasts: 189 nCPM
- migrating cytotrophoblasts: 162 nCPM
- plasma cells: 116 nCPM
- decidual stromal cells: 113 nCPM
Immune cell
- plasmacytoid DC: 6.2 nTPM
- eosinophil: 5.5 nTPM
- MAIT T-cell: 2 nTPM
- NK-cell: 1.9 nTPM
- gdT-cell: 1.7 nTPM
- basophil: 1.6 nTPM
Brain region
- hippocampal formation: 74 nTPM
- choroid plexus: 74 nTPM
- medulla oblongata: 68 nTPM
- thalamus: 67 nTPM
- white matter: 65 nTPM
- pons: 65 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.15
- gnomAD missense Z
- 1.03
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity
- metal ion binding
- N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CHPF in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHPF as an antibody target. Whether an autoantibody or antibody against CHPF could matter depends on whether native CHPF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHPF is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CHPF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...